Avectas Ltd
- Biotech or pharma, therapeutic R&D
Avectas is accelerating the future of cell therapy with a flexible manufacturing platform that engineers healthier and more functional cells for patients. Avectas has developed an optimized non-viral transfection process aligned with GMP manufacturing and is advancing further processes to support cell therapy workflows.
Avectas is a private, international company with research facilities in Dublin and an office in Cambridge MA, USA. It has 33 employees and is led by a team of highly experienced pharmaceutical executives, and supported by a world-class Scientific Advisory Board of cancer cell therapy experts.